Literature DB >> 8586695

Comparison of arbitrarily primed PCR with restriction endonuclease and immunoblot analyses for typing Clostridium difficile isolates.

Y J Tang1, S T Houston, P H Gumerlock, M E Mulligan, D N Gerding, S Johnson, F R Fekety, J Silva.   

Abstract

Arbitrarily primed PCR (AP-PCR) was used to genotype 26 clinical isolates of Clostridium difficile previously analyzed by immunoblotting (IB) and 20 isolates typed by restriction endonuclease analysis (REA) with HindIII. Two levels of differentiation were achieved with the AP-PCR approach by use of two different arbitrary primers. With the 19-mer arbitrary primer T-7 (first level of differentiation), a good correlation was found between IB and AP-PCR typing. Twenty isolates grouped into six IB types were separated into seven major AP-PCR types. These seven AP-PCR groups were further discriminated into 12 subtypes after genotyping with the arbitrary primer PG-05 (second level of differentiation). The remaining six isolates, all of different IB types, showed a unique and distinct DNA banding pattern with both of the arbitrary primers, T-7 and PG-05. Twenty isolates representing 20 REA types from 15 REA groups were resolved into 13 AP-PCR DNA profiles with the arbitrary primer T-7. A good correlation was found at this level of differentiation between the major REA groups, Y and M, and AP-PCR typing. While AP-PCR with this primer failed to differentiate isolates in REA groups J, G, R, and B, AP-PCR with PG-05 resolved these four isolates into four distinct AP-PCR types. In addition, one of three M strains and one of four Y strains displayed a slightly different DNA banding pattern by AP-PCR (with PG-05) from that of the other strains in the group. We conclude that AP-PCR is a rapid and sensitive method which not only complements other typing schemes but also may be a substitute and prove to be especially suited for immediate epidemiological tracking of nosocomial infections due to C. difficile.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586695      PMCID: PMC228666          DOI: 10.1128/jcm.33.12.3169-3173.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Use of arbitrary primer PCR to type Clostridium difficile and comparison of results with those by immunoblot typing.

Authors:  G E Killgore; H Kato
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

2.  Typing of Legionella pneumophila strains by polymerase chain reaction-mediated DNA fingerprinting.

Authors:  A van Belkum; M Struelens; W Quint
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

3.  Use of the arbitrary primer polymerase chain reaction for investigating an outbreak of Clostridium difficile-associated diarrhea in AIDS patients.

Authors:  F Barbut; N Mario; J Frottier; J C Petit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

4.  Value of molecular epidemiologic analysis in a nosocomial methicillin-resistant Staphylococcus aureus outbreak.

Authors:  F C Fang; M McClelland; D G Guiney; M M Jackson; A I Hartstein; V H Morthland; C E Davis; D C McPherson; J Welsh
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

5.  Random amplified polymorphic DNA assay is less discriminant than pulsed-field gel electrophoresis for typing strains of methicillin-resistant Staphylococcus aureus.

Authors:  P Saulnier; C Bourneix; G Prévost; A Andremont
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

6.  Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems.

Authors:  C R Clabots; S Johnson; K M Bettin; P A Mathie; M E Mulligan; D R Schaberg; L R Peterson; D N Gerding
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

7.  Comparison of arbitrarily primed polymerase chain reaction, ribotyping, and monoclonal antibody analysis for subtyping Legionella pneumophila serogroup 1.

Authors:  P Gomez-Lus; B S Fields; R F Benson; W T Martin; S P O'Connor; C M Black
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Genotyping of Clostridium difficile isolates.

Authors:  J Silva; Y J Tang; P H Gumerlock
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

9.  Specific detection of toxigenic strains of Clostridium difficile in stool specimens.

Authors:  P H Gumerlock; Y J Tang; J B Weiss; J Silva
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

10.  Wide diversity of Clostridium difficile types at a tertiary referral hospital.

Authors:  M H Samore; K M Bettin; P C DeGirolami; C R Clabots; D N Gerding; A W Karchmer
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

View more
  9 in total

1.  Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals.

Authors:  Jane W Marsh; Mary M O'Leary; Kathleen A Shutt; A William Pasculle; Stuart Johnson; Dale N Gerding; Carlene A Muto; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  Comparison of restriction enzyme analysis, arbitrarily primed PCR, and protein profile analysis typing for epidemiologic investigation of an ongoing Clostridium difficile outbreak.

Authors:  M E Rafferty; A L Baltch; R P Smith; L H Bopp; C Rheal; F C Tenover; G E Killgore; D M Lyerly; T D Wilkins; D J Schoonmaker; G E Hannett; M Shayegani
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

3.  Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA.

Authors:  G Ackermann; Y J Tang; R Kueper; P Heisig; A C Rodloff; J Silva; S H Cohen
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

4.  Extended multilocus variable-number tandem-repeat analysis of Clostridium difficile correlates exactly with ribotyping and enables identification of hospital transmission.

Authors:  S E Manzoor; H E Tanner; C L Marriott; J S Brazier; K J Hardy; S Platt; P M Hawkey
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

5.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Comparison of DNA fingerprinting methods for use in investigation of type E botulism outbreaks in the Canadian Arctic.

Authors:  Daniel Leclair; Franco Pagotto; Jeffrey M Farber; Brigitte Cadieux; John W Austin
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

7.  Isolation and molecular characterization of Clostridium difficile strains from patients and the hospital environment in Belarus.

Authors:  L Titov; N Lebedkova; A Shabanov; Y J Tang; S H Cohen; J Silva
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Genotyping of outbreak-related and sporadic isolates of Clostridium difficile belonging to serogroup C.

Authors:  P van Dijck; V Avesani; M Delmée
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

9.  Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea.

Authors:  Yajarayma Tang-Feldman; Susan Mayo; Joseph Silva; Stuart H Cohen
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.